Phase I safety and antigenicity of TA-GW: a recombinant HPV6 L2E7 vaccine for the treatment of genital warts

Author: Thompson H.S.G.   Davies M.L.   Holding F.P.   Fallon R.E.   Mann A.E.   O'Neill T.   St Clair Roberts J.  

Publisher: Elsevier

ISSN: 0264-410X

Source: Vaccine, Vol.17, Iss.1, 1999-01, pp. : 40-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content